Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
China United Kingdom South Korea Germany Japan India
Inquriy
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name list{{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID

{{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID

{{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID Structural

What is {{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID?

Toxicity

Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate < 30 mL/min/1.73m2).

The Uses of {{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID

Diagnostic contrast agent for vascular enhancement of MRI scans.

Indications

Gadofosveset trisodium is indicated for use as a contrast agent in magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease.

Background

Gadofosveset trisodium is an intravenous contrast agent used with magnetic resonance angiography(MRA), which is a non-invasive way of imaging blood vessels. The agent allows for the vascular system to be imaged more clearly by the MRA. In this way, gadofosveset trisodium is used to help diagnose certain disorders of the heart and blood vessels.

Pharmacokinetics

Gadofosveset causes signal enhancement by shortening the T1 of water molecules that interact with it. The contrast agent complex's rotation rate is the primary factor determining the magnitude of relaxation enhancement. This relaxation enhancement increase only occurs when bound to human serum albumin.

Metabolism

Gadofosveset does not undergo measurable metabolism.

Safety information for {{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID

New Products

4-Iodo-3,5-dimethylbenzonitrile 2-fluoro-4-iodoaniline 2-(3-Methyl-1,2,4-oxadiazol-5-yl)acetic acid (as potassium salt) 6,6'-methylenebis(9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one) 3-Bromo-2-fluorobenzoic acid Quinuclidine-4-carbonitrile N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine（RM for Indian lab) (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid Tetrabutylammonium perchlorate N,O-Dimethylhydroxylamine hydrochloride (R)-1-Benzyl-3-pyrrolidinecarbonitrile Bupropian related compound F Lantanoprost rc B Clidinium Bromide Impurity Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity N-Nitroso hydroxy Cetrizine EP Impurity-A 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 1,4-bis(methylsulfonyl)butane 4-Cyano-N-Methacryloyl-3-Trifluoromethyl Aniline 5-Methyl-1,3-benzenediacetonitrile 4-Fluorothiophenol 1-methyl amino-2,4-dinitro benzene

Related products of tetrahydrofuran

Diethylenetriaminepentaacetic acid
Diethylenetriaminepentaacetic acid
4,4-DIPHENYLCYCLOHEXANOL
4,4-DIPHENYLCYCLOHEXANOL
Bicine
Bicine
{{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID
{{(R)-2-(BIS-CARBOXYMETHYL-AMINO)-3-[(4,4-DIPHENYL-CYCLOHEXYLOXY)-HYDROXY-PHOSPHORYLOXY]-PROPYL}-[2-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-AMINO}-ACETIC ACID
N-(2-HYDROXYETHYL)IMINODIACETIC ACID
N-(2-HYDROXYETHYL)IMINODIACETIC ACID

You may like

  • 6,6'-bis(difluoromethoxy)-2,2'-bis((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H,1'H-5,5'-bibenzo[d]imidazole 98%
    6,6'-bis(difluoromethoxy)-2,2'-bis((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H,1'H-5,5'-bibenzo[d]imidazole 98%
    2115779-15-0
    View Details
  • 4-bromo-1H-pyrazole-3-carboxylic acid 98%
    4-bromo-1H-pyrazole-3-carboxylic acid 98%
    13745-17-0
    View Details
  • 230971-72-9 (1-((2'-(2-((1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl)-2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol 98%
    230971-72-9 (1-((2'-(2-((1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl)-2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol 98%
    230971-72-9
    View Details
  • 1941177-45-2 98%
    1941177-45-2 98%
    1941177-45-2
    View Details
  • Isopropyl amine Hydrochloride 99%
    Isopropyl amine Hydrochloride 99%
    15572-56-2
    View Details
  • 19501-58-7 99%
    19501-58-7 99%
    19501-58-7
    View Details
  • Cyclopropane-1,1-dicarboxylic acid 99%
    Cyclopropane-1,1-dicarboxylic acid 99%
    598-10-7
    View Details
  • 230971-71-8 (1-((2'-(1-((1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl)-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol 98%
    230971-71-8 (1-((2'-(1-((1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl)-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol 98%
    230971-71-8
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
HomePage About Us Contact us Terms Privacy Chemicalbook
Land Line: 040 - 40102781 Mobile contact: +91 9550333722